OMDA Stock Forecast & Price Target

Omada Health is attractive fundamentally because its employer-, health plan-, and PBM-led model creates sticky, recurring revenue with structurally low customer acquisition costs, high retention, and visibility into growth as member cohorts mature. The company also sits in a large and underserved cardiometabolic market, with about 25 million covered lives, roughly 1.1 million enrolled members, 4.4% average enrollment versus much higher utilization at top accounts, and strong tailwinds from GLP-1 demand and multi-condition care. Management’s raised long-term targets for 80% gross margin and 30% EBITDA margin, plus expected 20%+ revenue growth and improving scale leverage from AI, support a view that profitability can expand meaningfully despite customer concentration risk.

Omada Health is facing a difficult fundamental setup because its growth depends on persuading members to enroll and stay engaged, even though digital health participation has historically been weak and its services must compete with simpler consumer-focused offerings. Omada Health is also exposed to meaningful concentration and execution risk, with 66% of total revenue coming from affiliates and a reliance on channel partners and clinical outcomes to sustain revenue, while the need to navigate HIPAA and healthcare regulations adds cost and limits agility. Omada Health is further challenged by a crowded competitive market, supplier and cybersecurity vulnerabilities, and the possibility that virtual care alone may not fully replace in-person evaluation, making its path to durable profitability less certain despite a 128% net revenue retention rate and 1Q:26 operating expense declines of about 5% y/y on a percent of revenue basis.